DataMeds AI
MEDS
13 hedge funds and large institutions have $205K invested in DataMeds AI in 2026 Q1 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 9 closing their positions.
200% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 1
0.12% less ownership
Funds ownership: 2.16% → 2.03% (-0.12%)
32% less funds holding
Funds holding: 19 → 13 (-6)
44% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 9
73% less capital invested
Capital invested by funds: $773K → $205K (-$568K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$61.3K |
| 2 |
Jane Street
New York
|
+$14.3K |
| 3 |
AA
ACT Advisors
Asheville,
North Carolina
|
+$9.72K |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$5.57K |
| 5 |
SL
Sentinus LLC
Oak Brook,
Illinois
|
+$5.57K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$20.5K |
| 2 |
VF
Virtu Financial
New York
|
-$18K |
| 3 |
TSS
Two Sigma Securities
New York
|
-$11.1K |
| 4 |
SG
StoneX Group
New York
|
-$8.65K |
| 5 |
Vanguard Personalized Indexing Management
Oakland,
California
|
-$7.26K |
MEDS Hedge Fund Activity: Q1 2026 in Review
13 of the 8,204 institutional investors tracked by Wall St. Rank reported a position in DataMeds AI (MEDS) for Q1 2026, worth a combined $205K — down 73% from $773K a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of MEDS and 5 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 3 added.
The largest buyer was Geode Capital Management, adding an estimated $61.3K. The largest seller was XTX Topco, cutting an estimated $20.5K.
- 13 institutional investors held DataMeds AI (MEDS) as of Q1 2026, down from 19 in Q4 2025.
- Funds reported $205K of DataMeds AI stock for Q1 2026, down 73% quarter-over-quarter.
- 5 funds opened new DataMeds AI positions in Q1 2026 and 9 closed out, a net change of -4 holders.
- The largest DataMeds AI buyer in Q1 2026 was Geode Capital Management, an estimated $61.3K added.
- The largest DataMeds AI seller in Q1 2026 was XTX Topco, an estimated $20.5K sold.
Based on aggregated 13F filings for Q1 2026.